Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-17-001714
Filing Date
2017-02-22
Accepted
2017-02-22 16:26:29
Documents
36
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO QUARTERLY REPORT f10q0316a2_americanbrivision.htm 10-Q/A 293599
2 CERTIFICATION f10q0316a2ex31i_americanbri.htm EX-31.1 11090
3 CERTIFICATION f10q0316a2ex31ii_americanbri.htm EX-31.2 11373
4 CERTIFICATION f10q0316a2ex32i_americanbri.htm EX-32.1 3800
5 CERTIFICATION f10q0316a2ex32ii_americanbri.htm EX-32.2 4231
  Complete submission text file 0001213900-17-001714.txt   1396250

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20160331.xml EX-101.INS 189579
7 XBRL SCHEMA FILE mtoo-20160331.xsd EX-101.SCH 18717
8 XBRL CALCULATION FILE mtoo-20160331_cal.xml EX-101.CAL 17618
9 XBRL DEFINITION FILE mtoo-20160331_def.xml EX-101.DEF 33813
10 XBRL LABEL FILE mtoo-20160331_lab.xml EX-101.LAB 127378
11 XBRL PRESENTATION FILE mtoo-20160331_pre.xml EX-101.PRE 94827
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 17628783
SIC: 2834 Pharmaceutical Preparations